VIRxSYS Management and Scientific Team
VIRxSYS has a highly experienced management and scientific team that helped move the Company’s technology from a laboratory at The Johns Hopkins University to the clinic in less than five years.
Management and Team Members
Riku H. Rautsola, PhD – President & CEO
Gary J. McGarrity, PhD – Executive Vice President of Scientific and Clinical Affairs
Gerard F. Fleury, CPA – Executive Vice President & CFO
Laurent Humeau, PhD – Vice President of Research and Development
Tessio Rebello, PhD – Vice President of Clinical Affairs
Yajin Ni, MD, PhD – Director of Developmental Sciences
Franck Lemiale, PhD - Director of Immunobiology
Shuyuan Zhang, PhD – Vice President of Manufacturing
Lawrence Michaelis, MD – Chairman
Helmer P. K. Agersborg, Jr., PhD
James V. Kehoe
L. William McIntosh, MBA
John P. Phair, MD
Riku Rautsola, PhD
William N. Sick, Jr. – Co-Founder
William J. Turner, MBA – Co-Founder
Prince K. Zachariah, MD, PhD
Franz W. Schmadl, M.Sc.
"The Board of VIRxSYS is proud of the team that has been assembled within the company. The breadth and depth of these world-class experts in their respective fields is most impressive. These people, and their considerable skills and dedication, have allowed us to move the company's "first-in-class" technology into human clinical trials in the U.S. in less than five years, which is a remarkable accomplishment."
Lawrence L. Michaelis, MD, Chairman of the Board of Directors of VIRxSYS